Results 151 to 160 of about 8,213 (210)

Ototoxicity in Cancer Therapies. [PDF]

Oral Dis
da Costa SS, Treister NS, de Melo Alves CE.   +2 more
europepmc   +1 more source

Once-daily aminoglycoside therapy: Potential ototoxicity [PDF]

, 1997
Kirkpatrick, Cmj, Duffull, SB, Begg, EJ
core  

Ototoxicity and cognitive outcomes among very young children treated for brain tumors: Findings from a multisite, prospective, longitudinal trial. [PDF]

Neuro Oncol
Conklin HM, Salman NA, Bass JK, Huang J, Onar-Thomas A, Ashford JM, Harman J, Ali JS, Swain MA, Harder LL, Carlson-Green BL, Miller JM, Wallace J, Kaner RJ, Merchant TE, Robinson GW, Gajjar A.   +16 more
europepmc   +1 more source

High-frequency thresholds: sound suite versus hospital room [PDF]

, 1992
French-St. George, Marilyn, Goebel, Joel, Potts, Lisa G, Valente, L. Maureen, Valente, Michael   +4 more
core   +1 more source

Baicalin attenuates cisplatin-induced cochlear hair cell damage by modulating the ROS-p38 MAPK signaling pathway. [PDF]

Front Cell Dev Biol
Zhang Q, Wang Y, Zhang C, Li S, Yin Q, Zhou C, Dong C, Bu C.   +7 more
europepmc   +1 more source

The influence of targeted therapies in the inner ear. [PDF]

Front Pharmacol
Bonilla T, DiFatta J, Bas Infante E, Goncalves S.   +3 more
europepmc   +1 more source

Concepts for aminoglycoside serum level monitoring [PDF]

, 2017
WENK, M.
core  

Plazomicin: A promising novel antimicrobial in the era of bacterial resistance (Review). [PDF]

Exp Ther Med
Abouelkheir M, Taha AE, Taher IA, Saad Eldien HM, Bakhaat GA.   +4 more
europepmc   +1 more source

High-frequency thresholds: circumaural earphone versus insert earphone [PDF]

, 1992
Goebel, Joel, Valente, L. Maureen, Valente, Michael   +2 more
core   +1 more source